|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/32 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3589661 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18712044.9 |
| Date of filing the European patent application | 2018-02-28 | |
| (97) | Date of publication of the European application | 2020-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/US2018/020154 |
| Date | 2018-02-28 |
| (87) | Number | WO 2018/160654 |
| Date | 2018-09-07 |
| (30) | Number | Date | Country code |
| 201762466239 P | 2017-03-02 | US | |
| 201762469317 P | 2017-03-09 | US | |
| 201762486876 P | 2017-04-18 | US |
| (72) |
BENYUNES, Mark, C. , US
ROSS, Graham, Alexander , GB
|
| (73) |
Genentech, Inc. ,
1 DNA Way, South San Francisco, CA 94080,
US
F. Hoffmann-La Roche AG , Grenzacherstrasse 124, 4070 Basel, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Adjuvantinis HER2 atžvilgiu teigiamo krūties vėžio gydymas |
| ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-01-22 | 8 | 185.00 EUR |
| 2026-02-28 |